Cargando…

Radiological Characteristics of Renal Lesions During Tuberous Sclerosis Complex: Impact of Mechanistic Target of Rapamycin Inhibitor Treatment

Detalles Bibliográficos
Autores principales:	Pfirmann, Pierre, Jambon, Eva, Aupy, Jérome, Bernhard, Jean-christophe, Bakis, Hugo, Combe, Christian, Grenier, Nicolas, Rigothier, Claire
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546737/ https://www.ncbi.nlm.nih.gov/pubmed/36217523 http://dx.doi.org/10.1016/j.ekir.2022.07.168

Ejemplares similares

Vascularization of Cell-Laden Microfibres by Femtosecond Laser Processing
por: Verit, Isabel, et al.
Publicado: (2022)

Insulinoma and Tuberous Sclerosis: A Possible Mechanistic Target of Rapamycin (mTOR) Pathway Abnormality?
por: Kang, Michael Yoon, et al.
Publicado: (2017)

Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex
por: Lu, Yiyang, et al.
Publicado: (2020)

Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
por: Kim, Won Seop
Publicado: (2011)

Topical rapamycin for facial angiofibromas in tuberous sclerosis complex
por: Safa, Gilles
Publicado: (2017)

Retraction: Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
por: Kim, Won Seop
Publicado: (2013)

Cooperative benefit for the combination of rapamycin and imatinib in tuberous sclerosis complex neoplasia
por: Govindarajan, Baskaran, et al.
Publicado: (2012)

Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex
por: Sato, Atsushi, et al.
Publicado: (2012)

Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial
por: Cabrera-López, Cristina, et al.
Publicado: (2012)

Antiepileptic Effect and Safety Profile of Rapamycin in Pediatric Patients With Tuberous Sclerosis Complex
por: Sadowski, Krzysztof, et al.
Publicado: (2022)

The Efficacy and Safety of Rapamycin in Children with Tuberous Sclerosis: A Cross-sectional Study
por: TEHRANI, Fateme, et al.
Publicado: (2023)

Efficacy and Safety of Topical Mechanistic Target of Rapamycin Inhibitors for Facial Angiofibromas in Patients with Tuberous Sclerosis Complex: A Systematic Review and Network Meta-Analysis
por: Lin, Yu-Ting, et al.
Publicado: (2022)

Renal involvement is frequent in adults with primary mitochondrial disorders: an observational study
por: Bakis, Hugo, et al.
Publicado: (2022)

Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model
por: Rauktys, Aubrey, et al.
Publicado: (2008)

Tuberous Sclerosis Associated with Polycystic Kidney Disease: Effects of Rapamycin after Renal Transplantation
por: Rosado, C., et al.
Publicado: (2013)

Rapamycin-Insensitive Up-Regulation of Adipocyte Phospholipase A2 in Tuberous Sclerosis and Lymphangioleiomyomatosis
por: Li, Chenggang, et al.
Publicado: (2014)

Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models
por: Lee, Nancy, et al.
Publicado: (2009)

Cutaneous Lesions as the Sole Presentation of Tuberous Sclerosis
por: Ahmed, Mohanad, et al.
Publicado: (2020)

MicroRNA-21 is Induced by Rapamycin in a Model of Tuberous Sclerosis (TSC) and Lymphangioleiomyomatosis (LAM)
por: Trindade, Anil J., et al.
Publicado: (2013)

Rapamycin therapy for neonatal tuberous sclerosis complex with cardiac rhabdomyomas: A case report and review
por: Mao, Shanshan, et al.
Publicado: (2017)

Safety of inactivated COVID-19 vaccine in tuberous sclerosis complex patients with epilepsy treated with rapamycin
por: Lu, Qian, et al.
Publicado: (2022)

Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779
por: Messina, Michael P, et al.
Publicado: (2007)

Progression of Fetal Brain Lesions in Tuberous Sclerosis Complex
por: Gelot, Antoinette Bernabe, et al.
Publicado: (2020)

Infantile Spasms in Tuberous Sclerosis Complex: Lesion or Network?
por: Joshi, Charuta, et al.
Publicado: (2021)

Combined Targeting of mTOR and Akt Using Rapamycin and MK-2206 in The Treatment of Tuberous Sclerosis Complex
por: Ji, Shuang, et al.
Publicado: (2017)

A Case Report of Pediatric Patient with Tuberous Sclerosis and Radiologically Isolated Syndrome
por: Sforza, Giorgia, et al.
Publicado: (2023)

Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysis
por: Li, Min, et al.
Publicado: (2019)

Tuberous sclerosis
por: George, Anisha, et al.
Publicado: (2015)

A CT-Based Clinical, Radiological and Radiomic Machine Learning Model for Predicting Malignancy of Solid Renal Tumors (UroCCR-75)
por: Garnier, Cassandre, et al.
Publicado: (2023)

Genotype-phenotype correlation of renal lesions in the tuberous sclerosis complex
por: Muto, Yoshinari, et al.
Publicado: (2022)

Space-Occupying Intraventricular Vascular Lesion in Tuberous Sclerosis Complex
por: Lv, Hongtao, et al.
Publicado: (2022)

Topical Rapamycin Therapy to Alleviate the Cutaneous Manifestations of Tuberous Sclerosis Complex: A Double-Blind, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of Topically Applied Rapamycin
por: Koenig, Mary Kay, et al.
Publicado: (2012)

The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway
por: Hartman, Tiffiney R., et al.
Publicado: (2009)

A rare case of bilateral renal angiomyolipoma: Radiological findings of tuberous sclerosis complex
por: Ali, Sajjad, et al.
Publicado: (2023)

Mechanistic Target of Rapamycin Pathway in Epileptic Disorders
por: Kim, Jang Keun, et al.
Publicado: (2019)

Tuberous sclerosis complex associated intracranial lesion found by antenatal ultrasound
por: Hanes, Ilana, et al.
Publicado: (2020)

Histological Patterns of Skin Lesions in Tuberous Sclerosis Complex: A Panorama
por: Cascarino, Marine, et al.
Publicado: (2021)

Cardiac rhabdomyomas and cerebral lesions in 4 pediatric patients with tuberous sclerosis
por: Fogante, Marco, et al.
Publicado: (2023)

AUTISM IN TUBEROUS SCLEROSIS
por: Khanna, Rakesh, et al.
Publicado: (1991)

Tuberous sclerosis with rhabdomyoma
por: Ajay, V., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_169lrh5l77fmgi9q7qpc74q2mu